Board of Directors

Ali Behbahani, M.D.
General Partner, New Enterprise Associates

Dr. Kapil Dhingra
Former Head, Roche Oncology Development

Dr. Wendy Dixon
Former Global Marketing Head, Bristol Myers Squibb

David M. Epstein, Ph.D.
Co-Founder, Former President & CEO of Black Diamond Therapeutics

Samarth (Sam) Kulkarni, Ph.D.
CEO, CRISPR Therapeutics AG

Alexander Mayweg, Ph.D.
Managing Partner, Versant Ventures

Garry E. Menzel, Ph.D.
Former President and CEO of TCR2 Therapeutics

Rajeev Shah
Managing Partner, RA Capital Management

Mark A. Velleca, M.D., Ph.D.
President & Chief Executive Officer